PCDHGC5 and Alzheimer disease: The increased Pcdhγc5 enhances synaptic inhibition and elevates GABAergic protein levels, which may contribute to pathogenic excitatory/inhibitory imbalance in an AD mouse model (Table 1) (Li et al., 2017).